7 ms·
You may disagree but the history of the Office of Inspector General crapping on sub-200 headcount biotech and pharma startups doesn't mesh with any of that. Kee
by forgetfreeman 4y ago
You may disagree but the history of the Office of Inspector General crapping on sub-200 headcount biotech and pharma startups doesn't mesh with any of that. Keep in mind smaller firms don't put up anywhere near the fight a multinational like Pfizer is capable of, and the OIG knows this.